期刊文献+

组织因子和组织因子途径抑制物1对无复流作用的实验研究 被引量:6

Effects of tissue factor pathway inhibitor-1 on no-reflow in a rabbit model
原文传递
导出
摘要 目的观察缺血再灌注时兔心肌组织和血浆中组织因子(TF)和组织因子途径抑制物1(TFPI-1)水平的变化,研究外源性TFPI-1对无复流严重程度的影响,探讨TF激活的外源性凝血系统及TFPI-1抑制途径在无复流发病过程中的作用。方法40只新西兰大白兔随机分为4组(每组10只):缺血再灌注组(IR组,结扎回旋支120min,再灌注60min)、缺血再灌注TFPI-1组(TFPI-1组,再灌注时rTFPI-1 100ng/kg静脉注射,1ng·kg^-1·min。静脉滴注)、缺血组(结扎回旋支180min)和假手术组,每组10只。用硫磺素S和Evan’s蓝活体染色区分无复流区和缺血区。无复流严重程度用无复流面积/缺血面积表示。用逆转录-聚合酶链反应方法测定无复流区、缺血区及正常区心肌组织TF和TFPI-1mRNA表达水平,ELISA方法测定开胸前、冠状动脉结扎前即刻及结扎120min、再灌注10和60min血浆TF和TFPI-1水平。结果开胸前、冠状动脉结扎前即刻及结扎120min,各组血浆TF、TFPI-1水平差异无统计学意义(P〉0.05);再灌注10和60min时,IR组血浆TF水平均显著高于缺血组和假手术组[10min:(20.7±4.1)pg/ml比(13.9±2.2)pg/ml(P〈0.001),(20.7±4.1)pg/ml比(13.2±2.6)pg/ml(P〈0.001);60min:(15.8±2.6)pg/ml比(13.5±1.6)pg/ml(P〈0.05),(15.8±2.6)pg/ml比(12.1±0.7)pg/ml(P〈0.001)]。再灌注10min时,IR组血浆TFPI-1水平较缺血组及假手术组无明显变化(P〉0.05);60min时,血浆TFPI-1水平[(9.7±1.6)ng/m1]反而显著低于缺血组[(11.6±1.6).g/ml,P〈0.05]及假手术组[(10.1±1.3).g/ml,P〈0.01]。IR组无复流区心肌组织TFmRNA表达高于缺血组及假手术组(P〈0.05或P〈0.001);TFPI-1mRNA表达较缺血组无明显变化(P〉0.05)。TFPI-1组无复流严重程度明显低于IR组(0.39±0. Objective To investigate the role of plasma tissue factor (TF) and tissue factor pathway inhibitor-1 (TFPI-1) level and to observe the effect of extrinsic TFPI-1 on no-reflow (NR) in a rabbit model of ischemia/reperfusion. Methods Rabbits were randomized into four groups ( n = 10 each) : ischemic- reperfusion group (IR, subjected to 120 minutes of coronary artery occlusion and followed by 60 minutes of reperfusion) ; ischemic- reperfusion TFPI-1 group ( 100 ng/kg bolus and 1 ng·kg^-1· min -1 infusion during reperfusion) ; ischemic group (subjected to 180 minutes of coronary artery occlusion) and sham group. The NR area and ischemic area were determined by thioflavin S and Evan's blue staining in vivo. Plasma TF and TFPI-1 levels were measured before operation, before and at 120 minute, s post coronary artery ligation, 10 and 60 minutes after reperfusion by ELISA. Results Plasma TF and TFPI-1 levels before and at 120 minutes post coronary artery ligation were similar among the four groups (all P 〉 0. 05). At 10 and 60 minutes after reperfusion, the plasma TF levels in the IR group was significantly higher than those in ischemic group and sham group [ 10 minutes : ( 20. 7 ±4. 1 ) pg/ml vs. ( 13.9 ± 2. 2 ) pg/ml ( P 〈 0. 001 ), ( 20. 7 ± 4. 1 )pg/ml vs. ( 13.2 ± 2.6 ) pg/ml (P 〈 0. 001 ) ; 60 minutes: ( 15.8 ± 2. 6 ) pg/rrd vs. ( 13.5± 1.6) pg/ml(P〈0.05), (15.8±2.6) pg/mlvs. (12.1 ±0.7) pg/ml(P〈0.001)] while the plasma TFPI-1 levels were similar among IR, ischemie and sham groups at 10 minutes after reperfusion and at 60 minutes after reperfusion (all P 〉 0. 05 ). TFPI-1 level [ (9.7 ± 1.6) ng/ml] was significantly lower in the IR group than in the ischemie group [ ( 11.6 ± 1.6 ) ng/ml, P 〈 0. 05 ] and sham group [ ( 10. 1± 1.3 ) ng/ml, P 〈 0. 01 ] . TF mRNA expression in the NR area in IR group was significantly up-regulated compared to the ischemie group ( P 〈 O. 05 ) and sham
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2009年第12期1113-1118,共6页 Chinese Journal of Cardiology
基金 国家自然科学基金资助项目(30772289)
关键词 心肌再灌注损伤 凝血致活酶 无复流 Myocardial repeffusion injury Thromboplastin No reflow
  • 相关文献

参考文献17

  • 1Brosh D, Assali AR, Mager A, et al. Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality. Am J Cardiol, 2007,99:442- 445. 被引量:1
  • 2Rezkalla SH, Kloner RA. Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory. Catheter Cardiovasc Interv, 2008, 72:950-957. 被引量:1
  • 3Golino P,Ragni M, Cirillo P, et al. Recombinant human, active site-blocked factor VII a reduces infarct size and no-reflow phenomenon in rabbits. Am J Physiol Heart Circ Physiol, 2000, 278 : 1507-1516. 被引量:1
  • 4Bonderman D,Teml A, Jakowitsch J, et al. Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque. Blood, 2002, 99: 2794-2800. 被引量:1
  • 5Kloner RA, Alker K, Campbell C, et al. Does tissue-type plasminogen activator have direct beneficial effects on the myocardium independent of its ability to lyse intracoronary thrombi? Circulation, 1989, 79 : 1125-1136. 被引量:1
  • 6徐萍,齐晓云,李春华,张继红,刘冬梅,刘洁,王万粮.急性心肌梗死患者直接介入治疗后无再流与血浆组织因子及其途径抑制物的关系[J].中华心血管病杂志,2008,36(11):1013-1015. 被引量:6
  • 7Ott I, Malcouvier V, Schomig A, et al. Proteolysis of tissue factor pathway inhibitor-1 by thmmbolysis in acute myocardial infarction. Circulation, 2002, 105 : 279-281. 被引量:1
  • 8Kloner RA, Ganote CE, Jennings RB. The " no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest, 1974, 54:1496-1508. 被引量:1
  • 9Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurements of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA, 1987, 84: 1404-1407. 被引量:1
  • 10Entman ML, Smith CW. Postreperfusion inflammation: A model for reaction to injury in cardiovascular disease. Cardiovasc Res, 1994, 28: 1301-1311. 被引量:1

二级参考文献7

  • 1Resnic FS, Wainstein M, Lee MK, et al. No-reflow is an independent predictor of death and myocardial infalction after percutaneous coronary intervention. Am Heart J, 2003, 145 : 42- 46. 被引量:1
  • 2Brosh D, Assali AR, Mager A, et al. Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality. Am J Cardiol, 2007,99 : 442- 445. 被引量:1
  • 3Bonderman D, Teml A, Jakowitsch J, et al. Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaques. J Blood, 2002,99:2794-2800. 被引量:1
  • 4Migdalski A, Kotschy M, Jawien A. Tissue factor, tissue factor pathway inhibitor and vascular endothelial growth factor-A in carotid atherosclerotic plaques. Eur J Vasc Endovasc Surg, 2005, 30:41-47. 被引量:1
  • 5Iwaknra K, ho H, lkushima M, et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coil Cardiol,2003,41:1-7. 被引量:1
  • 6Broze GJ Jr. Tissue factor pathway inhibitor and the revised theory of coagulation. Annu Rev Med, 1995,46 : 103-112. 被引量:1
  • 7Golino P, Ragni M, Cimmino G, et al. Role of tissue factor pathway inhibitor in the regulation of tissue factor dependent blood coagulation. Cardiovasc Drug Rev,2002 ,20 :67-80. 被引量:1

共引文献5

同被引文献44

引证文献6

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部